379 related articles for article (PubMed ID: 22251626)
1. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
2. MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.
Tang G; Du R; Tang Z; Kuang Y
J Cell Biochem; 2018 Apr; 119(4):3725-3731. PubMed ID: 29236328
[TBL] [Abstract][Full Text] [Related]
3. Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.
Yura M; Fukuda K; Matsuda S; Irino T; Nakamura R; Kawakubo H; Takeuchi H; Kitagawa Y
BMC Cancer; 2022 Oct; 22(1):1064. PubMed ID: 36243683
[TBL] [Abstract][Full Text] [Related]
4. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
5. The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer.
Wang WN; Chen Y; Zhang YD; Hu TH
Tumour Biol; 2013 Jun; 34(3):1865-71. PubMed ID: 23519840
[TBL] [Abstract][Full Text] [Related]
6. MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma.
Liu YX; Bai JX; Li T; Fu XQ; Chen YJ; Zhu PL; Chou JY; Yin CL; Li JK; Wang YP; Wu JY; Yu ZL
Phytomedicine; 2019 Nov; 64():153084. PubMed ID: 31514083
[TBL] [Abstract][Full Text] [Related]
7. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc.
Du J; Fan JJ; Dong C; Li HT; Ma BL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5301-5314. PubMed ID: 31298382
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
9. CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.
Li F; Zou Z; Suo N; Zhang Z; Wan F; Zhong G; Qu Y; Ntaka KS; Tian H
Med Oncol; 2014 Sep; 31(9):180. PubMed ID: 25142946
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
Pan MR; Hou MF; Chang HC; Hung WC
J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
[TBL] [Abstract][Full Text] [Related]
11. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
Tutunea-Fatan E; Majumder M; Xin X; Lala PK
Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
[TBL] [Abstract][Full Text] [Related]
12. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
[TBL] [Abstract][Full Text] [Related]
13. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1.
Mi Y; Liu F; Liang X; Liu S; Huang X; Sang M; Geng C
Neoplasma; 2019 Jan; 66(1):54-62. PubMed ID: 30509089
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
[TBL] [Abstract][Full Text] [Related]
17. The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis.
Mohammed MM; Shaker O; Ramzy MM; Gaber SS; Kamel HS; Abed El Baky MF
Life Sci; 2021 Aug; 279():119691. PubMed ID: 34102193
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
19. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
